Taiwan FDA registration c6e72d4158956c2becd6ee9e3ead6037
LIAISON Toxo IgG II
TW: 禮亞尚弓漿蟲IgG檢測試劑 第二代
Taiwan·Risk Class 2·MD·DIASORIN ITALIA S.P.A.·Registered Jul 22, 2014 – Jul 22, 2024ExpiredRegistration details
- Analysis ID
- c6e72d4158956c2becd6ee9e3ead6037
- License Form
- Ministry of Health Medical Device Import No. 026275
- Customs Code
- DHA05602627508
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product utilizes chemical cold light particle immunoassay (CLIA) to quantify specific IgG antibodies against Toxoplasma gondii in human serum and plasma. It can be used with a Reasan analyzer.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3780 Toxoplasma rodent serum reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 22, 2014
- Expiry Date
- Jul 22, 2024
About this record
Access comprehensive regulatory information for LIAISON Toxo IgG II in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c6e72d4158956c2becd6ee9e3ead6037 and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices